Quality Allen Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.32 M
- Company Age 28 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -1.46%
- Ebitda -1.46%
- Net Worth
- Total Assets
About Quality Allen Pharma
Quality Allen Pharma Private Limited (QAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 June 1996 and has a history of 28 years and eight months. Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.32 M, as per Ministry of Corporate Affairs (MCA) records.
Gour Sarkar, Mriganka Sarkar, Gobinda Saha, and Three other members serve as directors at the Company.
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239WB1996PTC079942
- Company No.
079942
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 1996
- Date of AGM
-
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Quality Allen Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gour Sarkar  | Managing Director | 02-Aug-2001 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mriganka Sarkar | Director | 08-Jun-2007 | Current |
| Gobinda Saha | Director | 08-Jun-2007 | Current |
| Ajay Singhania | Director | 02-Aug-2001 | Current |
| Krishna Singhania | Director | 15-Jan-2005 | Current |
| Sulakshmi Sarkar | Director | 02-Aug-2001 | Current |
Financial Performance of Quality Allen Pharma.
Quality Allen Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 1.46% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quality Allen Pharma?
In 2019, Quality Allen Pharma had a promoter holding of 21.33% and a public holding of 78.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jupiter Pharmaceuticals LtdGour Sarkar and Mriganka Sarkar are mutual person
Allen Healthcare Co LimitedGour Sarkar, Gobinda Saha and 1 more are mutual person
Cygnus Vyapar Private LimitedAjay Singhania and Krishna Singhania are mutual person
Cygnus Multimedia Private LimitedKrishna Singhania is a mutual person
Cygnus Journalism Private LimitedAjay Singhania is a mutual person
Cygnus Investments &Finance Private LimitedKrishna Singhania is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Quality Allen Pharma?
Unlock and access historical data on people associated with Quality Allen Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quality Allen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quality Allen Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.